Home/Filings/4/0001209191-19-026004
4//SEC Filing

Leung Thomas 4

Accession 0001209191-19-026004

CIK 0001501756other

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 5:05 PM ET

Size

5.9 KB

Accession

0001209191-19-026004

Insider Transaction Report

Form 4
Period: 2019-04-24
Leung Thomas
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-04-24+450,000450,000 total
    Exercise: $6.62Exp: 2029-04-23Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of April 24, 2019 (the "Vesting Commencement Date"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Issuer

Adverum Biotechnologies, Inc.

CIK 0001501756

Entity typeother

Related Parties

1
  • filerCIK 0001774051

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 5:05 PM ET
Size
5.9 KB